A poster discussing the potential use of complimentary and alternative medical treatments for Lyme Disease

Hessberger, Michelle

Siminovich-Blok, Barbara

UB ScholarWorks

 Lyme Disease (LD) is currently the most common vector-borne disease in the United States1.  This disease is complicated to diagnose and cure in its acute state and highly morbid in its chronic state.  Given the complications derived from the presence of this pathogen , the  varying antigenic response in its host and the difficulty to establish a timely diagnosis in at least half of the cases, we decided to focus our research on:  a) Designing a new Diagnostic Protocol that will help with  faster identification of the  spirochete  presence and associated co- infections,  plus help us establish a baseline  of autoimmune and degenerative diseases propensity in the affected individual. b)  Compiling  CAM (Complimentary and Alternative Medicine) treatments to compliment antibiotic therapies and prevent/treat co-morbidities associated with the chronic manifestation of Lyme. Designing and Implementing a Novel CAM Protocol Using Laboratory Analysis and Supplementation to Reduce Morbidity Outcomes in the Treatment of Lyme Disease Barbara Siminovich-Blok, ND MS, Michelle Hessberger MS Department of Naturopathic Medicine University of Bridgeport, Bridgeport, CT  Common Symptoms Lyme Babesia Anaplasma Bartonella Fatigue X X X X Headache X X X X Swollen joints X       Fever X X X X Chills X X X X Swollen lymph nodes X     X Encephalopathy X X X   Malaise X X X X Skin complications Bull’s eye rash   Rarely rash Rash Nausea/Vomiting   X X X Flu-like symptoms X X X X Muscle/joint aches X   X   Confusion X   X   Incubation Period 3 days -6 mo. 1-52 wks 1-30 days 3-50 days References: 1. CDC Editorial Note. Lyme Disease- United States 2003-2005. MMWR 2007; 56: 573-576. 2. Center for Disease Control (CDC) at: http://www.cdc.gov/ncidod/dvbid/lyme/ld_statistics.htm  3. Levin MI, Fish D. Acquisition of coinfection and simultaneous transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis ticks. Infection and Immunity 2000 Apr; 68(4):2183-86. 4. Piesman J, Mather TN, Telford SR, 3rd, Spielman A. Concurrent Borrelia burgdorferi and Babesia microti infection in nymphal Ixodes dammini. J Clin Microbiol. 1986 Sep;24(3):446–447. 5. Cotte V, Bonnet S, Le Rhun D, Le naour E, Chauvin A, Boulouis H. Transmission of Bartonella henselae by Ixodes ricinius. Emerging infectious Diseases 2008 July 1; at http://www.thefreelibrary.com/Transmission+of+Bartonella+henselae+by+Ixodes+ricinus.-a0181225570  6. Eskow E, Rao RV, Mordechai E. (2001) Concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae: evidence for a novel tick-borne disease complex. Archives of Neurology 58: 1357-1363. 7. Nyarko E., Grab D.J., and Dumler J.S. (2006) Anaplasma phagocytophilum -infected neutrophils enhance transmigration of Borrelia burgdorferi across the human blood brain barrier in vitro. International Journal for Parasitology. Available online March 2006 at http://www.sciencedirect.com/science/journal/00207519  8. Krause PJ,Telford III SR, Spielman A, Sikand V, Ryan R, Christianson D, Burke G, Brassard P, Pollack R, Peck J, Persing DH. (1996) Concurrent Lyme disease and Babesiosis: Evidence for increased severity and duration of illness. JAMA 275: 1657-1660. 9. Hedberg N. Lyme Disease – The Functional Medicine Approach. Teleconference from FMTown. 2011 Feb 2 at www.fmtown.com  10. CDC at: www.cdc.gov/ticks/diseases  11. Bransfield RC. Lyme Disease, comorbid tick-borne diseases, and neuropsychiatric disorders. Psychiatric Times 2007 Dec 1; 24(14): 59-62.  12.The Physican’s Guide to Laboratory Test Selection and Interpretation at: www.arupconsult.com  13. Datar A, Navroop K, Patel S, Luecke DF, Sapi E. InVitro Effectiveness of Samento and Banderol Herbal Extracts on the Different Morphological Forms of Borrelia burgdorferi. Townsend Letter 2010 July; at www.newhaven.edu/news-events/82773.pdf  14: ILADS at http://www.ilads.org/files/ILADS_Guidelines.pdf Symptoms and Common Co-Infections: Typical symptoms of Lyme Disease overlap with other diseases transmitted by deer ticks, including Babesia microti, Anaplasma phagtocyphilum (formerly Ehrlichia phagocytophila), and Bartonella henselae 3-5. viruses such as TBEV, WNV, Powassan encephalitis, and other bacteria such as Q fever (Coxiella), Brucella, Tularemia, and Rickettsia species 10.Transmission of multiple pathogens by Ixodes ticks is common and can further complicate diagnosis, treatment and resolution of symptoms 6.  Mimickers of the disease in the chronic state are : Protozoan FL-1953, EBV, CMV, Mycoplasma, Chlamydia . See below for overlapping symptoms. Justification for More Comprehensive Testing: Concurrent tick-borne infections statistically decrease the likelihood of the characteristic bull’s eye rash and impairs diagnosis through conventional laboratory testing 6-8. Additionally, multiple tick-borne infections increase severity and duration of morbidity 6-8. Lyme disease is also a great mimicker of many chronic diseases including autoimmune and degenerative diseases, justifying the need for establishing a patient health baseline 9,11.   Basic Laboratory Testing: Borrelia burgdorferi Ab ELISA with reflex to IgG & IgM Western blot: early disease to isolate antigenic response to Lyme 6 weeks post tick bite (its  reliability is controversial 11, false positive with other spirochetal disease, autoimmune disease, EBV, and periodontitis 12). -CBC with differential: abnormal WBCs, chronic anemia, hemolytic anemia -Comprehensive Metabolic Panel: imbalanced electrolyte levels, metabolic acidosis, elevated liver enzymes, BUN, uric acid, and creatinine  Step One Comprehensive /Baseline Testing and Possible Findings 9,11,12: -Autoimmune Panel: increased morbidity if positive, easier follow up in chronic state -HLADR2, HLADR4 genotypes: increased morbidity if positive -Borrelia burgdorferi C6 Peptide Ab ELISA with reflex to IgG & IgM Western blot: more specific assay -Babesia microti, Anaplasma phagocytophilum, and Bartonella henselae Ab IgG & IgM by IFA: positive if co-infections are present -Viral Panel: to rule out other causes of symptoms -3-OH Vitamin D3: low -Thyroid Panel (TSH, TT4, FT4, Anti-TPO Ab, Anti-TG Ab): elevated TSH, maybe low TT4 and FT4, positive for antibodies -RBC Magnesium: < 2.0 -CD-57 panel (Lab Corp): Absolute CD8-/CD57+ lymphocytes are often low in Lyme Disease and Chlamydia. Ideal range is >200.   Step Two Comprehensive /Baseline Testing and Possible Findings 9,11,12: -Fasting Glucose, Insulin, HbA1c: altered glucose, elevated HbA1c, insulin resistance -Urinary Organic Acids and Amino Acids: elevated amino acids indicate a state of catabolic breakdown from disease, certain elevations in organic acids correlate with physiological malfunctions or infections -Fibrinogen: increased clotting factors -Anti-cardiolipin Ab, Anti-phospholipid Ab: positive if Borrelia burrows into the arterial lining -C3a and C4a (Lab Corp): elevated in Lyme and autoimmune disease Treatment therapies: (usually prescribed in this order)  Oral: amoxicillin, azithromycin , cefuroxime , clarithromycin, doxycycline and tetracycline IV: ceftriaxone, cefotaxime, penicillin imipenem, azithromycin and doxycycline IM: benzathine penicillin Combination:  Oral amoxicillin, cefuroxime or cefdinir combined with a macrolide (azithromycin or clarithromycin) NSAIDS: for pain and inflammation  CAM Treatments 9, 13: NK Cell and Phagocytotic Immune Boosting to Reduce Microbial Load: Antioxidants, Beta-glucans, Astragalus, Shiitake Inflammatory Cytokine Reduction:  Samento, Cat’s Claw, Curcumin, Boswellia, Quercetin, Omega-3 Fatty Acids, Probiotics Anti-microbials:  Olive leaf, colloidal silver, EGCG , Samento and Banderol to decrease biofilm formation A-L Complex (for Borrelia), A-BAB(for Babesia), A-BART (for Bartonella) Anti-virals: Lauricidin (monolauric acid) in coconut, L-lysine, Melissa officinalis,  Glycyrrhiza glabra Maintenance of Tight Junctions to Decrease Mobility of Infection: ALA, vitamin D, Ginkgo biloba, DHEA, Glutathione, NAC Dietary: Avoid sugar, gluten and casein; add protein to stabilize blood sugar and adrenal function,  high water (1/2 body wt in oz.), high fiber, and alkaline diet high in vegetables Adjunct treatments: Hyperthermy –hot Epsom salt baths or IR sauna to trigger immune function , Hyperbaric Chamber: shown positive preliminary results Reduction of Increased Clotting: Hydrolytic enzymes, Capsaicin, Vitamin E, CoQ10, EPA/DHA  During a six year period cases of Lyme  disease were reported to CDC by 49 states and DC, the number of cases is increasing rapidly  2 .   CONCLUSIONS: After our thorough literary search we were able to design a protocol for comprehensive testing and consequent individualization of Lyme (and co-infection) treatments. Our preliminary data demonstrates that integrating antibiotic and CAM therapies help decrease the symptomatology and may prevent the chronic state of the disease by improving the immune system.  We look forward to implementing our lab test protocol as a standard for our clinic patients. We predict a reduction in chronic Lyme morbidity and more clarification on what pathology might be present  through better diagnostics and a combinatorial approach to treatment using CAM and antibiotics.  # 66 :  __  __  __ 

Designing and Implementing a Novel CAM Protocol using Laboratory Analysis and Supplementation to Reduce Morbidity Outcomes in the Treatment of Lyme Disease

https://scholarworks.bridgeport.edu/xmlui/bitstream/handle/123456789/239/66.Siminovich-Blok.pdf?sequence=2&isAllowed=y

Designing and Implementing a Novel CAM Protocol using Laboratory Analysis and Supplementation to Reduce Morbidity Outcomes in the Treatment of Lyme Disease

Abstract

Similar works

Full text

Available Versions

UB ScholarWorks